Education
About Us
Working with TipRanks
Follow Us
Intelligent Bio Solutions (INBS)
NASDAQ:INBS
RESEARCH TOOLSreports
INBS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $4.64
Previous CloseN/A
Volume32.28K
Average Volume (3M)262.40K
Market Cap
$14.65M
Enterprise Value$3.26M
Total Cash (Recent Filing)$1.12M
Total Debt (Recent Filing)$1.08M
Price to Earnings (P/E)―
Beta2.64
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.44
Shares Outstanding6,783,543
10 Day Avg. Volume86,977
30 Day Avg. Volume262,399
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.76
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.22
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.29
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Intelligent Bio Solutions News
PremiumCompany Announcements
Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval
PremiumCompany Announcements
Intelligent Bio Solutions Plans U.S. Market Entry in 2025
PremiumCompany Announcements
Intelligent Bio Solutions Partners with Avon Freight Group---
Ownership Overview
3.09% Insiders
0.61% Mutual Funds
0.15% Other Institutional Investors
95.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
INBS FAQ
What was Intelligent Bio Solutions’s price range in the past 12 months?
Intelligent Bio Solutions lowest stock price was $1.00 and its highest was $4.64 in the past 12 months.
What is Intelligent Bio Solutions’s market cap?
Intelligent Bio Solutions’s market cap is $14.65M.
When is Intelligent Bio Solutions’s upcoming earnings report date?
Intelligent Bio Solutions’s upcoming earnings report date is May 07, 2025 which is in 43 days.
How were Intelligent Bio Solutions’s earnings last quarter?
Currently, no data Available
Is Intelligent Bio Solutions overvalued?
According to Wall Street analysts Intelligent Bio Solutions’s price is currently Overvalued.
Does Intelligent Bio Solutions pay dividends?
Intelligent Bio Solutions does not currently pay dividends.
What is Intelligent Bio Solutions’s EPS estimate?
Intelligent Bio Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intelligent Bio Solutions have?
Intelligent Bio Solutions has 6,783,543 shares outstanding.
What happened to Intelligent Bio Solutions’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Intelligent Bio Solutions?
Currently, no hedge funds are holding shares in INBS
---
Company Description
Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
---
Technical Analysis
---